Meeting Banner
Abstract #3927

Imaging immunotherapy resistance in melanoma in vivo and in vitro employing magnetic resonance

Shivanand Pudakalakatti1, Ashvin Jaiswal2, Prasanta Dutta1, Michael Curran2, and Pratip Bhattacharya1

1Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, United States, 2Immunology, University of Texas MD Anderson Cancer Center, Houston, TX, United States

Identifying immunotherapy resistance and underlying molecular mechanisms of resistance will help in stratifying immunotherapy treatment effectively. However, identifying immunotherapy resistance and its causative mechanisms are elusive. Here we have developed mouse models of immunotherapy resistance and identified molecular mechanisms indicating immunotherapy resistance employing magnetic resonance. In vitro studies showed adaptations in metabolic pathways of glycolysis, fatty acid and purine synthesis in resistant cell lines. In vivo experiments with 1-13C hyperpolarized pyruvate revealed higher pyruvate to lactate conversion in immunotherapy resistant mice compared to responding ones. Hence, pyruvate to lactate ratio can be a potential biomarker to identify immunotherapy resistance in vivo.

This abstract and the presentation materials are available to members only; a login is required.

Join Here